|
|
||||||||
Clinical Chemistry, Vol 38, 2501-2505, Copyright © 1992 by American Association for Clinical Chemistry
PS Henthorn and MP Whyte
Section of Medical Genetics, University of Pennsylvania School of Veterinary Medicine, Philadelphia 19104.
Hypophosphatasia is an inborn error of metabolism that is characterized clinically by defective bone mineralization and biochemically by deficient activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP) in serum and in tissues. Clinical severity is extremely variable, ranging from death in utero to pathologic fractures first presenting in adulthood. Severe forms of the disease are inherited in an autosomal recessive fashion; the modes of transmission of mild forms are uncertain. Deficiency of TNSALP activity in this condition suggests that mutations in the TNSALP "candidate" gene are the primary defects. This hypothesis was supported in 1988 by the demonstration, in one inbred infant, that an identical missense mutation in both alleles of the gene encoding TNSALP caused lethal hypophosphatasia. Here we summarize the work leading to that discovery and discuss the recent identification of additional missense mutations in the TNSALP gene associated with the entire clinical spectrum of hypophosphatasia.
The following articles in journals at HighWire Press have cited this article:
![]() |
H.-Y. Kang, C.-R. Shyr, C.-K. Huang, M.-Y. Tsai, H. Orimo, P.-C. Lin, C. Chang, and K.-E. Huang Altered TNSALP Expression and Phosphate Regulation Contribute to Reduced Mineralization in Mice Lacking Androgen Receptor Mol. Cell. Biol., December 15, 2008; 28(24): 7354 - 7367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice J. Histochem. Cytochem., April 1, 2007; 55(4): 375 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Le Du and J. L. Millan Structural Evidence of Functional Divergence in Human Alkaline Phosphatases J. Biol. Chem., December 13, 2002; 277(51): 49808 - 49814. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hessle, K. A. Johnson, H. C. Anderson, S. Narisawa, A. Sali, J. W. Goding, R. Terkeltaub, and J. L. Millan Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization PNAS, July 9, 2002; 99(14): 9445 - 9449. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Müller, M. Yamazaki, T. Michigami, T. Kageyama, E. Schönau, P. Schneider, and K. Ozono Asp361Val Mutant of Alkaline Phosphatase Found in Patients with Dominantly Inherited Hypophosphatasia Inhibits the Activity of the Wild-Type Enzyme J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 743 - 747. [Abstract] [Full Text] |
||||
![]() |
M. Y. Yang, Z. Wang, M. MacPherson, J. A. T. Dow, and K. Kaiser A Novel Drosophila Alkaline Phosphatase Specific to the Ellipsoid Body of the Adult Brain and the Lower Malpighian (Renal) Tubule Genetics, January 1, 2000; 154(1): 285 - 297. [Abstract] [Full Text] |
||||
![]() |
A. Suzuki, G. Palmer, J.-P. Bonjour, and J. Caverzasio Regulation of Alkaline Phosphatase Activity by p38 MAP Kinase in Response to Activation of Gi Protein-Coupled Receptors by Epinephrine in Osteoblast-Like Cells Endocrinology, July 1, 1999; 140(7): 3177 - 3182. [Abstract] [Full Text] |
||||
![]() |
G. Cai, T. Michigami, T. Yamamoto, N. Yasui, K. Satomura, M. Yamagata, M. Shima, S. Nakajima, S. Mushiake, S. Okada, et al. Analysis of Localization of Mutated Tissue-Nonspecific Alkaline Phosphatase Proteins Associated with Neonatal Hypophosphatasia Using Green Fluorescent Protein Chimeras J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3936 - 3942. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |